GlassScriptPhysician profile
Anora D Henderson
NPI 1063593762
$950.47
in general payments reported to CMS, 2019-2025
15 companies · $18.96 in 2025
The $18.96 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $132 · 2020: $87.20 · 2021: $226 · 2022: $194 · 2023: $179 · 2024: $113 · 2025: $18.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $311.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $311.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $235.62 | 2019-2024 | Prolia, Evenity, Otezla |
| Novo Nordisk INC | $224.74 | 2019-2023 | Ozempic, Rybelsus |
| Lilly USA, LLC | $105.58 | 2022-2025 | Mounjaro, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $103.43 | 2021-2024 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $68.51 | 2022-2023 | Eliquis |
| Astrazeneca Pharmaceuticals LP | $35.71 | 2019-2021 | |
| Medtronic, INC. | $27.76 | 2022 | |
| Pfizer INC. | $27.38 | 2019-2021 | |
| Avanir Pharmaceuticals, INC. | $25.50 | 2020-2021 | |
| Organogenesis INC. | $22.45 | 2023 | Puraply |
| Biohaven Pharmaceutical Holding Company LTD. | $19.68 | 2022 | |
| Janssen Pharmaceuticals, INC | $17.79 | 2021 | |
| Exact Sciences Corporation | $13.25 | 2024 | Cologuard Collection Kit |
| Shire North American Group INC | $12.27 | 2019 | |
| Merck Sharp & Dohme LLC | $10.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anora Henderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.